Eli Lilly Earnings, Revenue Miss in Q2
2022.08.04 13:58
Eli Lilly Earnings, Revenue Miss in Q2
Investing.com – Eli Lilly (NYSE:LLY) reported on Thursday second quarter earnings that missed analysts’ forecasts and revenue that fell short of expectations.
Eli Lilly announced earnings per share of $1.25 on revenue of $6.49B. Analysts polled by Investing.com anticipated EPS of $1.71 on revenue of $6.85B.
Eli Lilly shares are up 13% from the beginning of the year, still down 6.41% from its 52 week high of $335.33 set on July 15. They are outperforming the S&P 500 which is down 12.82% from the start of the year.
Eli Lilly follows other major Healthcare sector earnings this month
Eli Lilly’s report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
